Data / Drug companies / Costco Wholesale Company
Costco Wholesale Company: 47 products in the FDA NDC directory, labeler code 63981
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Costco Wholesale Company (labeler code 63981) lists 47 products in the FDA National Drug Code Directory, covering 28 finished drugs by generic name. By type: 47 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on August 19, 2026.
The request: Watch Costco Wholesale Company (FDA labeler code 63981): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63981
- Products in commercial distribution
- 47
- Packages
- 48
- Finished drugs by generic name
- 28
- Prescription products
- 0
- Over the counter products
- 47
- Flagged as original packager
- 38 of 38 products that carry the flag
- Started marketing in the last 12 months
- 1
- Products with a marketing end date set
- 1
- Earliest marketing start
- May 24, 1988
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 37 | 78.7% |
| Over the counter monograph drugs | 9 | 19.1% |
| New drug applications (NDA) | 1 | 2.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 47 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 9 | 19.1% |
| Lozenge | 4 | 8.5% |
| Tablet | 4 | 8.5% |
| Gum, chewing | 4 | 8.5% |
| Solution | 3 | 6.4% |
| Tablet, extended release | 3 | 6.4% |
| Gel | 3 | 6.4% |
| Capsule, liquid filled | 3 | 6.4% |
| Tablet, coated | 2 | 4.3% |
| Aerosol, foam | 2 | 4.3% |
| Tablet, film coated, extended release | 2 | 4.3% |
| Tablet, delayed release | 2 | 4.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Kirkland signature minoxidil | 63981-098 | Aerosol, foam | Generic drugs (ANDA) | August 19, 2026 |
| Kirkland signature allerclear d 24 hr | 63981-138 | Tablet, extended release | Generic drugs (ANDA) | October 3, 2025 |
| Kirkland signature arthritis pain relief | 63981-799 | Gel | Generic drugs (ANDA) | June 10, 2025 |
| Ibuprofen minis | 63981-192 | Capsule, liquid filled | Generic drugs (ANDA) | November 1, 2024 |
| Kirkland Ultra Stregth Antacid 171AB | 63981-171 | Tablet | Over the counter monograph drugs | July 8, 2024 |
| Severe Cold and Flu Plus Congestion | 63981-795 | Kit | Over the counter monograph drugs | June 30, 2023 |
| Kirkland signature mucus dm | 63981-812 | Tablet, extended release | Generic drugs (ANDA) | May 19, 2023 |
| Kirkland signature arthritis pain relief | 63981-599 | Gel | Generic drugs (ANDA) | March 3, 2023 |
| Diclofenac sodium | 63981-211 | Gel | Generic drugs (ANDA) | December 31, 2022 |
| Acetaminophen | 63981-019 | Tablet, coated | Over the counter monograph drugs | October 12, 2022 |
| Acetaminophen PM | 63981-056 | Tablet, coated | Over the counter monograph drugs | October 4, 2022 |
| Stool Softener Laxative | 63981-853 | Capsule, liquid filled | Over the counter monograph drugs | March 18, 2022 |
| Kirkland Signature Lansoprazole | 63981-582 | Capsule, delayed release | Generic drugs (ANDA) | November 22, 2021 |
| Kirkland signature aller fex | 63981-847 | Tablet, film coated | Generic drugs (ANDA) | August 19, 2021 |
| Kirkland signature minoxidil | 63981-032 | Solution | Generic drugs (ANDA) | May 13, 2021 |
| Kirkland Signature Nicotine | 63981-190 | Lozenge | Generic drugs (ANDA) | May 8, 2020 |
| Kirkland Signature Nicotine | 63981-124 | Lozenge | Generic drugs (ANDA) | May 8, 2020 |
| Kirkland signature aller tec d | 63981-147 | Tablet, film coated, extended release | Generic drugs (ANDA) | March 30, 2020 |
| Sleep Aid | 63981-986 | Tablet | Generic drugs (ANDA) | May 3, 2019 |
| Kirkland signature allerclear d 12 hr | 63981-723 | Tablet, film coated, extended release | Generic drugs (ANDA) | May 7, 2018 |
| Ibuprofen | 63981-598 | Capsule, liquid filled | Generic drugs (ANDA) | February 6, 2018 |
| Kirkland signature esomeprazole magnesium | 63981-898 | Capsule, delayed release | Generic drugs (ANDA) | September 22, 2017 |
| KIRKLAND SIGNATURE ALLERCLEAR D 24 HR Extended Release | 63981-724 | Tablet, extended release | Generic drugs (ANDA) | August 25, 2017 |
| Kirkland signature quit 4 | 63981-309 | Gum, chewing | Generic drugs (ANDA) | March 21, 2017 |
| Kirkland Signature Quit 2 | 63981-012 | Gum, chewing | Generic drugs (ANDA) | March 21, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.